Clinical Trials List
2013-11-13 - 2019-12-27
Phase III
Terminated10
ICD-10E11.610
Type 2 diabetes mellitus with diabetic neuropathic arthropathy
ICD-10E11.618
Type 2 diabetes mellitus with other diabetic arthropathy
ICD-10E11.620
Type 2 diabetes mellitus with diabetic dermatitis
ICD-10E11.621
Type 2 diabetes mellitus with foot ulcer
ICD-10E11.622
Type 2 diabetes mellitus with other skin ulcer
ICD-10E11.628
Type 2 diabetes mellitus with other skin complications
ICD-10E11.630
Type 2 diabetes mellitus with periodontal disease
ICD-10E11.638
Type 2 diabetes mellitus with other oral complications
ICD-10E11.649
Type 2 diabetes mellitus with hypoglycemia without coma
ICD-10E11.65
Type 2 diabetes mellitus with hyperglycemia
ICD-10E11.69
Type 2 diabetes mellitus with other specified complication
ICD-9250.80
Diabetes with other specified manifestations, Type II [non-insulin dependent type][NIDDM type][adult-onset type] or unspecified type, not stated as uncontrolled
-
Trial Applicant
PAREXEL INTERNATIONAL CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Stop recruiting
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
61 participants
-
Global
8252 participants
